Clinical Trials Browser

Phase 2 × Transplantation, Autologous × Other hematologic neoplasm × Clear all

NCT01716793 2012-11-01

Risk-adapted Therapy for Adult Acute Myeloid Leukemia.

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute